| # | Drug | Count |
|---|---|---|
| 0 | EPINEPHRINE | 20 |
| 1 | IBUPROFEN | 14 |
| 2 | PANTOPRAZOLE | 13 |
| 3 | METFORMIN | 12 |
| 4 | GLIPIZIDE | 10 |
| 5 | IBUPROFEN 200 MG | 10 |
| 6 | IBUPROFEN 200MG | 10 |
| 7 | NALOXONE HCL | 10 |
| 8 | ONDANSETRON | 10 |
| 9 | ONDANSETRON HYDROCHLORIDE | 10 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | TRACE ELEMENTS 4 | 1 | 0.1429 |
| 1 | TRACE ELEMENTS 5 | 2 | 0.0870 |
| 2 | TETRAHYDROZOLINE HCL | 1 | 0.0714 |
| 3 | ASCORBIC ACID, VITAMIN A PALMITATE, CHOLECALCIFEROL, THIAMINE HYDROCHLORIDE, RIBOFLAVIN-5 PHOSPHATE SODIUM, PYRIDOXINE HYDROCHLORIDE, NIACINAMIDE, DEXPANTHENOL, ALPHA-TOCOPHEROL ACETATE, VITAMIN K1, FOLIC ACID, BIOTIN, CYANOCOBALAMIN | 1 | 0.0588 |
| 4 | GLYCERIN, HYPROMELLOSE, POLYETHYLENE GLYCOL | 1 | 0.0500 |
| 5 | NALOXONE HCL | 10 | 0.0424 |
| 6 | HYDROCODONE BITARTRATE AND HOMATROPINE METHYLBROMIDE ORAL SOLUTION | 1 | 0.0400 |
| 7 | RIBOFLAVIN 5-PHOSPHATE OPHTHALMIC | 3 | 0.0326 |
| 8 | SODIUM CHLORIDE, SODIUM ACETATE ANHYDROUS, SODIUM GLUCONATE, POTASSIUM CHLORIDE, AND MAGNESIUM CHLORIDE | 1 | 0.0263 |
| 9 | EPINEPHRINE HYDROCHLORIDE | 2 | 0.0235 |
| # | Drug class | Count |
|---|---|---|
| 0 | Nonsteroidal Anti-inflammatory Drug [EPC] | 32 |
| 1 | Corticosteroid [EPC] | 23 |
| 2 | Catecholamine [EPC] | 22 |
| 3 | alpha-Adrenergic Agonist [EPC] | 20 |
| 4 | beta-Adrenergic Agonist [EPC] | 20 |
| 5 | Insulin Analog [EPC] | 16 |
| 6 | Anti-epileptic Agent [EPC] | 12 |
| 7 | Sulfonylurea [EPC] | 12 |
| 8 | Benzodiazepine [EPC] | 11 |
| 9 | Osmotic Laxative [EPC] | 11 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Humanized Monoclonal Antibody Fragment [EPC] | 3 | 0.0024 |
| 1 | Antifibrinolytic Agent [EPC] | 7 | 0.0012 |
| 2 | Oxytocic [EPC] | 2 | 0.0010 |
| 3 | CD22-directed Immunoconjugate [EPC] | 1 | 0.0006 |
| 4 | Adenosine Receptor Agonist [EPC] | 3 | 0.0005 |
| 5 | alpha-Adrenergic Agonist [EPC] | 20 | 0.0005 |
| 6 | Catecholamine [EPC] | 22 | 0.0004 |
| 7 | Non-Standardized Plant Allergenic Extract [EPC] | 4 | 0.0004 |
| 8 | Monoamine Oxidase Inhibitor [EPC] | 1 | 0.0004 |
| 9 | Antihypoglycemic Agent [EPC] | 1 | 0.0004 |